Clinical Trial: Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06860958) titled 'Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients' on March 01.

Brief Summary: Major depressive disorder (MDD) is one of the most common psychiatric disorders with serious socioeconomic consequences on daily life and health care costs. Despite the advent of newer antidepressants that target monoamine pathways, nearly 50% of patients have no response to first-line antidepressant therapy. Thus, a combination of medications with different strategies at the beginning of treatment could provide further therapeutic benefits to MDD patients

Study Start Date: March 20

Study Type: INTERVENTIONAL

Condition:...